How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.

Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L; Cancers (Basel). 2022; 14(22):

Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.

Singer, CF; Holst, F; Steurer, S; Burandt, EC; Lax, SF; Jakesz, R; Rudas, M; Stoger, H; Greil, R; Sauter, G; Filipits, M; Simon, R; Gnant, M; Abcsg, ABCSG CLIN CANCER RES. 2022; 28(18): 4112-4120.

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update

Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R WIEN KLIN WOCHENSCHR. 2022;

The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

Moyo, TK; Mendler, JH; Itzykson, R; Kishtagari, A; Solary, E; Seegmiller, AC; Gerds, AT; Ayers, GD; Dezern, AE; Nazha, A; Valent, P; van de Loosdrecht, AA; Onida, F; Pleyer, L; Cirici, BX; Tibes, R; Geissler, K; Komrokji, RS; Zhang, J; Germing, U; Steensma, DP; Wiseman, DH; Pfeilstoecker, M; Elena, C; Cross, NCP; Luebbert, M; Mesa, RA; Sanz, GF; Platzbecker, U; Patnaik, MM; Padron, E; Santini, V; Fenaux, P; Savona, MR; Kiladjian, JJ; Montalban-Bravo, G BMC CANCER. 2022; 22(1): 1013

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.

Nowakowski, GS; Yoon, DH; Peters, A; Mondello, P; Joffe, E; Fleury, I; Greil, R; Ku, M; Marks, R; Kim, K; Zinzani, PL; Trotman, J; Huang, D; Waltl, EE; Winderlich, M; Kurukulasuriya, NC; Ambarkhane, S; Hess, G; Salles, G CLIN CANCER RES. 2022; 28(18): 4003-4017.

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study

Diel, IJ; Greil, R; Janssen, J; Kluike, CW; Behera, B; Abbasi, A; Seesaghur, A; Kellner, M; Jaeger, C; Bjorklof, K; Tomova, A; Haslbauer, F SUPPORT CARE CANCER. 2022;

Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia

Akimova, E; Gassner, FJ; Greil, R; Zaborsky, N; Geisberger, R INT J MOL SCI. 2022; 23(3): 1094

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer

Woess, K; Sun, Y; Morio, H; Stierschneider, A; Kaufmann, A; Hainzl, S; Trattner, L; Kocher, T; Tockner, B; Leb-Reichl, V; Steiner, M; Brachtl, G; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Wally, V; Koller, U; Piñón Hofbauer, J; Guttmann-Gruber, C; Int J Mol Sci. 2022; 23(1):

Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.

Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L; BMC Cancer. 2022; 22(1): 51

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.

Diallo, A; Troseid, M; Simensen, VC; Boston, A; Demotes, J; Olsen, IC; Chung, F; Paiva, JA; Hites, M; Ader, F; Arribas, JR; Baratt-Due, A; Melien, O; Tacconelli, E; Staub, T; Greil, R; Tsiodras, S; Briel, M; Esperou, H; Mentre, F; Eustace, J; Saillard, J; Delmas, C; LeMestre, S; Dumousseaux, M; Costagliola, D; Rottingen, JA; Yazdanpanah, Y CLIN MICROBIOL INFEC. 2022; 28(1): 1-5.